Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
4
×
fda
4
×
indiana blog main
indiana top stories
life sciences
national blog main
raleigh-durham blog main
4
×
raleigh-durham top stories
amgen
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
migraine research foundation
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
calcitonin gene-related peptide
chronic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
lasmiditan
national
What
approval
4
×
drug
fda
won
4
×
migraine
new
class
decades
developed
friday
oral
acute
addresses
agency
aimmune
allergy
amgen
approved
arguments
awarded
big
candidates
causes
commercialized
companies
competitors
condition
drugs
eli
gets
giant
giving
head
immunotherapy
lasmiditan
late
lilly
lilly’s
make
medication
Language
unset
Current search:
approval
×
" clinical trials "
×
won
×
fda
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines